Proprietary Product
TraceWell
The Compliance Backbone for Healthcare Innovation. A proprietary SaaS platform owned and developed by Coyote & Quill.
What It Is
Built to solve the problems we lived with.
TraceWell is not a concept or a prototype. It is a live, actively developed healthcare SaaS platform — built by the same practitioner who navigated HIPAA compliance, FDA 21 CFR Part 11 requirements, and SOC 2 audit readiness simultaneously at a healthcare startup.
The platform is Coyote & Quill's flagship product and the most direct proof that the firm builds what it recommends.
| Product Type | SaaS — Healthcare Technology |
| Owner | Coyote & Quill LLC |
| Intellectual Property | Proprietary — copyright-protected |
| Development | Active — solo developer |
| Target Market | Healthcare providers, pharmacogenomics, preventive care |
Strategic Role
Why TraceWell exists within Coyote & Quill.
Credibility Anchor
Exhibit A
TraceWell is the answer to every client who asks "have you actually built anything?" It is a live product in active development — and it has been used in the field: a health system's clinical-innovation institute used TraceWell to track the development requirements for their genomics platform. Not a demo. Not a side project.
Revenue Channel
SaaS Licensing
TraceWell operates as a secondary revenue stream alongside consulting engagements — SaaS licensing to healthcare providers and platforms in the firm's target markets.
IP Asset
Defensible Value
TraceWell is proprietary and copyright-protected — and its real defensibility is domain depth: it is purpose-built for the compliance and traceability gap in healthcare innovation, not competing with generic EHR platforms.
Coming Soon
Full product details, screenshots, and investor one-pager will be added here ahead of launch.
Interested in early access or an investor conversation? Reach out directly.